Prostate Cancer Reports



Volume 3 Number 1
January 2015
Home > Prostate Cancer Reports > Volume 3, Year 2015 > Number 1, January

CONTENTS

SPECIAL SECTION ● Multiparametric MRI in Prostate Cancer


Detection, diagnosis and evaluation
Epidemiology and risk factors
Etiology and pathogenesis
Overall management
Prevention and screening
Prognosis and outcome
Quality of life
Treatment


DETECTION, DIAGNOSIS AND EVALUATION



Special section ● Multiparametric MRI in Prostate Cancer

Esen T, Turkbey B, Patel A, Futterer J.
Multiparametric MRI in prostate cancer. (Editorial)
Biomed Res Int. 2014;2014:296810. doi: 10.1155/2014/296810. Epub 2014 Dec 1.
Abstract | Full text | Related citations | Complete special issue (12 articles)


Bhavsar A, Verma S.
Anatomic imaging of the prostate.
Biomed Res Int. 2014;2014:728539. doi: 10.1155/2014/728539. Epub 2014 Aug 27.
Abstract | Full text | Related citations


Barchetti F, Panebianco V.
Multiparametric MRI for Recurrent Prostate Cancer Post Radical Prostatectomy and Postradiation Therapy.
Biomed Res Int. 2014;2014:316272. Epub 2014 May 25.
Abstract | Full text | Related citations


Bomers JG, Barentsz JO.
Standardization of multiparametric prostate MR imaging using PI-RADS.
Biomed Res Int. 2014;2014:431680. doi: 10.1155/2014/431680. Epub 2014 Jun 9.
Abstract | Full text | Related citations


George AK, Pinto PA, Rais-Bahrami S.
Multiparametric MRI in the PSA screening era.
Biomed Res Int. 2014;2014:465816. doi: 10.1155/2014/465816. Epub 2014 Aug 27.
Abstract | Full text | Related citations


Johnson LM, Choyke PL, Figg WD, Turkbey B.
The role of MRI in prostate cancer active surveillance.
Biomed Res Int. 2014;2014:203906. doi: 10.1155/2014/203906. Epub 2014 Nov 30.
Abstract | Full text | Related citations


Margolis DJ.
Multiparametric MRI for localized prostate cancer: lesion detection and staging.
Biomed Res Int. 2014;2014:684127. doi: 10.1155/2014/684127. Epub 2014 Nov 30.
Abstract | Full text | Related citations


Rothwax JT, George AK, Wood BJ, Pinto PA.
Multiparametric MRI in biopsy guidance for prostate cancer: fusion-guided.
Biomed Res Int. 2014;2014:439171. doi: 10.1155/2014/439171. Epub 2014 Jul 13.
Abstract | Full text | Related citations


Sankineni S, Osman M, Choyke PL.
Functional MRI in prostate cancer detection.
Biomed Res Int. 2014;2014:590638. doi: 10.1155/2014/590638. Epub 2014 Jul 23.
Abstract | Full text | Related citations


Puech P, Ouzzane A, Gaillard V, Betrouni N, Renard B, Villers A, Lemaitre L.
Multiparametric MRI-targeted TRUS prostate biopsies using visual registration.
Biomed Res Int. 2014;2014:819360. doi: 10.1155/2014/819360. Epub 2014 Dec 1.
Abstract | Full text | Related citations


Sankineni S, Osman M, Choyke PL.
Functional MRI in prostate cancer detection.
Biomed Res Int. 2014;2014:590638. doi: 10.1155/2014/590638. Epub 2014 Jul 23.
Abstract | Full text | Related citations


Vural M, Ertaş G, Onay A, Acar Ö, Esen T, Sağlıcan Y, Zengingönül HP, Akpek S.
Conspicuity of peripheral zone prostate cancer on computed diffusion-weighted imaging: comparison of cDWI1500, cDWI2000, and cDWI3000.
Biomed Res Int. 2014;2014:768291. doi: 10.1155/2014/768291. Epub 2014 Dec 1.
Abstract | Full text | Related citations


Wang S, Burtt K, Turkbey B, Choyke P, Summers RM.
Computer aided-diagnosis of prostate cancer on multiparametric MRI: a technical review of current research.
Biomed Res Int. 2014;2014:789561. doi: 10.1155/2014/789561. Epub 2014 Dec 1.
Abstract | Full text | Related citations


Hoeks CM, Barentsz JO, Hambrock T, Yakar D, Somford DM, Heijmink SW, Scheenen TW, Vos PC, Huisman H, van Oort IM, Witjes JA, Heerschap A, Fütterer JJ
Prostate cancer: multiparametric MR imaging for detection, localization, and staging.
Radiology. 2011 Oct;261(1):46-66. doi: 10.1148/radiol.11091822.
Abstract | Full text | Related citations

EPIDEMIOLOGY AND RISK FACTORS



Assayag J, Pollak MN, Azoulay L.
The Use of Aspirin and the Risk of Mortality in Patients with Prostate Cancer.
J Urol. 2014 Nov 14. pii: S0022-5347(14)04863-0. doi: 10.1016/j.juro.2014.11.018. [Epub ahead of print]
Abstract | Related citations


Aune D, Navarro Rosenblatt DA, Chan DS, Vieira AR, Vieira R, Greenwood DC, Vatten LJ, Norat T.
Dairy products, calcium, and prostate cancer risk: a systematic review and meta-analysis of cohort studies.
Am J Clin Nutr. 2015 Jan;101(1):87-117. doi: 10.3945/ajcn.113.067157. Epub 2014 Nov 19.
Abstract | Related citations


Bhindi B, Margel D, Hamilton RJ, Fernandes KA, Trottier G, Hersey KM, Finelli A, Trachtenberg J, Zlotta A, Kulkarni GS, Toi A, Evans A, van der Kwast TH, Fleshner NE.
The impact of the use of aspirin and other nonsteroidal anti-inflammatory drugs on the risk of prostate cancer detection on biopsy.
Urology. 2014 Nov;84(5):1073-80. doi: 10.1016/j.urology.2014.05.071. Epub 2014 Oct 24.
Abstract | Related citations


Daniyal M, Siddiqui ZA, Akram M, Asif HM, Sultana S, Khan A.
Epidemiology, etiology, diagnosis and treatment of prostate cancer.
Asian Pac J Cancer Prev. 2014;15(22):9575-8.
Abstract | Full text | Related citations


Kenfield SA, Van Blarigan EL, DuPre N, Stampfer MJ, L Giovannucci E, Chan JM.
Selenium supplementation and prostate cancer mortality.
J Natl Cancer Inst. 2014 Dec 12;107(1):360. doi: 10.1093/jnci/dju360. Print 2015 Jan.
Abstract | Related citations


Lovegrove C, Ahmed K, Challacombe B, Khan MS, Popert R, Dasgupta P.
Systematic review of prostate cancer risk and association with consumption of fish and fish-oils: analysis of 495,321 participants.
Int J Clin Pract. 2015 Jan;69(1):87-105. doi: 10.1111/ijcp.12514. Epub 2014 Dec 11.
Abstract | Full text | Related citations


Sawada N, Iwasaki M, Yamaji T, Shimazu T, Sasazuki S, Inoue M, Tsugane S; Japan Public Health Center–based Prospective Study Group.
Fiber intake and risk of subsequent prostate cancer in Japanese men.
Am J Clin Nutr. 2015 Jan;101(1):118-25. doi: 10.3945/ajcn.114.089581. Epub 2014 Nov 19.
Abstract | Related citations


Vidal AC, Howard LE, Moreira DM, Castro-Santamaria R, Adriole GL, Freedland SJ.
Aspirin, NSAID and risk of prostate cancer: Results from the REDUCE study.
Clin Cancer Res. 2014 Dec 17. pii: clincanres.2235.2014. [Epub ahead of print]
Abstract | Related citations


Wilson KM, Shui IM, Mucci LA, Giovannucci E.
Calcium and phosphorus intake and prostate cancer risk: a 24-y follow-up study.
Am J Clin Nutr. 2015 Jan;101(1):173-83. doi: 10.3945/ajcn.114.088716. Epub 2014 Nov 19.
Abstract | Related citations

ETIOLOGY AND PATHOGENESIS



Swanson GP, Epstein JI, Ha CS, Kryvenko ON.
Pathological characteristics of low risk prostate cancer based on totally embedded prostatectomy specimens.
Prostate. 2015 Mar;75(4):424-9. doi: 10.1002/pros.22928. Epub 2014 Nov 21.
Abstract | Related citations

OVERALL MANAGEMENT



Glaser AW, Corner JL.
Prostate Cancer Outcomes: The Three Questions.
Eur Urol. 2014 Nov 10. pii: S0302-2838(14)01037-9. doi: 10.1016/j.eururo.2014.10.023. [Epub ahead of print]
Abstract | Full text | Related citations


Pollock PA, Ludgate A, Wassersug RJ.
In 2124, half of all men can count on developing prostate cancer.
Current Oncology, Vol. 22, No.1, February 2015.
Abstract | Full text


Sohn M, Kwon T, Jeong IG, Hong S, You D, Hong JH, Ahn H, Kim CS.
Histologic variability and diverse oncologic outcomes of prostate sarcomas.
Korean J Urol. 2014 Dec;55(12):797-801. doi: 10.4111/kju.2014.55.12.797. Epub 2014 Nov 28.
Abstract | Full text | Related citations

PREVENTION AND SCREENING



Prostate-specific antigen

Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V, Kwiatkowski M, Lujan M, Määttänen L, Lilja H, Denis LJ, Recker F, Paez A, Bangma CH, Carlsson S, Puliti D, Villers A, Rebillard X, Hakama M, Stenman UH, Kujala P, Taari K, Aus G, Huber A, van der Kwast TH, van Schaik RH, de Koning HJ, Moss SM, Auvinen A; ERSPC Investigators.
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
Lancet. 2014 Dec 6;384(9959):2027-35. doi: 10.1016/S0140-6736(14)60525-0. Epub 2014 Aug 6.
Abstract | Related citations

PROGNOSIS AND OUTCOME



Abdollah F, Klett DE, Sood A, Sammon JD, Pucheril D, Dalela D, Diaz M, Peabody JO, Trinh QD, Menon M.
Predicting Pathologic Outcomes in Patients Undergoing Robot-Assisted Radical Prostatectomy for High Risk Prostate Cancer: A Preoperative Nomogram.
BJU Int. 2014 Nov 21. doi: 10.1111/bju.12998. [Epub ahead of print]
Abstract | Related citations


Moltzahn F, Karnes J, Gontero P, Kneitz B, Tombal B, Bader P, Briganti A, Montorsi F, Van Poppel H, Joniau S, Spahn M.
Predicting prostate cancer-specific outcome after radical prostatectomy among men with very high-risk cT3b/4 PCa: a multi-institutional outcome study of 266 patients.
Prostate Cancer Prostatic Dis. 2014 Dec 23. doi: 10.1038/pcan.2014.41. [Epub ahead of print]
Abstract | Related citations


Røder MA, Brasso K, Rusch E, Johansen J, Langkilde NC, Hvarness H, Carlsson S, Jakobsen H, Borre M, Iversen P.
Length of life gained with surgical treatment of prostate cancer: A population-based analysis.
Scand J Urol. 2014 Dec 2:1-7. [Epub ahead of print]
Abstract | Related citations


Yilmaz H, Ustuner M, Ciftci S, Yavuz U, Ozkan TA, Dillioglugil O.
Prostate volume predicts high grade prostate cancer both in digital rectal examination negative (ct1c) and positive (≥ct2) patients.
Int Braz J Urol. 2014 Sep-Oct;40(5):613-9. doi: 10.1590/S1677-5538.IBJU.2014.05.05.
Abstract | Full text | Related citations

QUALITY OF LIFE



Steineck G, Bjartell A, Hugosson J, Axén E, Carlsson S, Stranne J, Wallerstedt A, Persson J, Wilderäng U, Thorsteinsdottir T, Gustafsson O, Lagerkvist M, Jiborn T, Haglind E, Wiklund P; on behalf of the LAPPRO steering committee.
Degree of Preservation of the Neurovascular Bundles During Radical Prostatectomy and Urinary Continence 1 Year after Surgery.
Eur Urol. 2014 Oct 28. pii: S0302-2838(14)01019-7. doi: 10.1016/j.eururo.2014.10.011. [Epub ahead of print]
Abstract | Related citations

TREATMENT



Gnanapragasam VJ, Payne H, Syndikus I, Kynaston H, Johnstone T.
Primary Radical Therapy Selection in High-risk Non-metastatic Prostate Cancer.
Clin Oncol (R Coll Radiol). 2015 Mar;27(3):136-44. doi: 10.1016/j.clon.2014.11.004. Epub 2014 Nov 28.
Abstract | Full text | Related citations


Jereczek-Fossa BA, Colangione SP, Fodor C, Russo S, Cambria R, Zerini D, Bonora M, Cecconi A, Vischioni B, Vavassori A, Matei DV, Bottero D, Brescia A, Musi G, Mazzoleni F, Orsi F, Bonomo G, De Cobelli O, Orecchia R.
Radiotherapy in Prostate Cancer Patients With Pelvic Lymphocele After Surgery: Clinical and Dosimetric Data of 30 Patients.
Clin Genitourin Cancer. 2014 Nov 20. pii: S1558-7673(14)00258-4. doi: 10.1016/j.clgc.2014.11.007. [Epub ahead of print]
Abstract | Related citations


Tsai H, Keating NL, Van Den Eeden SK, Haque R, Cassidy-Bushrow AE, Yood MU, Smith MR, Potosky AL.
Risk of Diabetes among Patients Receiving Primary Androgen Deprivation Therapy for Clinically Localized Prostate Cancer.
J Urol. 2014 Dec 15. pii: S0022-5347(14)05079-4. doi: 10.1016/j.juro.2014.12.027. [Epub ahead of print]
Abstract | Related citations